Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

trial investigators

Research output: Contribution to journalArticlepeer-review

326 Scopus citations

Fingerprint

Dive into the research topics of 'Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials'. Together they form a unique fingerprint.

Medicine & Life Sciences